Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer
Clinical trial NCT03276013 · COMPLETED
Trial details
- NCT number
- NCT03276013
- Sponsor
- Vall d'Hebron Institute of Oncology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-30
- Primary completion
- 2020-04-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.